Form 4: Nurix Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations

Christine Ring, Chief Legal Officer of Nurix Therapeutics, sold shares to cover tax obligations related to the vesting of restricted stock units.

Summary

• Christine Ring, the Chief Legal Officer of Nurix Therapeutics, executed several transactions on January 30, 2025.
• These transactions involved the vesting of restricted stock units (RSUs) and the subsequent sale of shares to cover tax withholding obligations.
• A total of 7,674 shares were acquired through the vesting of RSUs at a price of $0.
• A total of 3,220 shares were sold at weighted average prices of $19.8068 and $20.3256.
• The sales were not discretionary trades but were mandated by the company's equity incentive plan.
• Following these transactions, Ms. Ring beneficially owns 32,538 shares of common stock and 33,750 restricted stock units.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider transactions, specifically the vesting of equity compensation and the subsequent sale of shares to cover tax obligations. Such transactions are common in publicly traded companies and are closely monitored by regulators and investors.

Comparison to Industry Standards

• The vesting of restricted stock units and subsequent 'sell to cover' transactions are standard practice for executive compensation in publicly traded companies.
• Many companies use similar mechanisms to manage tax obligations related to equity awards.
• The reported prices are within the normal range for stock transactions and are not indicative of any unusual activity.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and related to executive compensation.
• The sales are not discretionary and are mandated by the company's equity incentive plan.

Key Dates

Keywords

Nurix Therapeutics, NRIX, insider trading, Form 4, restricted stock units, RSU, tax withholding, equity compensation, Chief Legal Officer, Christine Ring